Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 35,696Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Rampex Labs

02 1Allchem Lifescience

03 5Guangdong Raffles PharmaTech Co Ltd

04 3Hangzhou Longshine Bio-Tech Co.,LTD

05 3Haohong (Qihe) Pharmaceutical Technology

06 4Jinan Tantu Chemicals

07 3Shenzhen HwaGen Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 1195768-20-7

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 1195768-19-4

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

CAS Number : 13036-57-2

End Use API : Dabrafenib Mesylate

About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...

Company Banner

04

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 60230-36-6

End Use API : Dabrafenib Mesylate

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

05

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 1195768-23-0

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

06

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 1195768-20-7

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

07

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 1195768-19-4

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

08

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 1195768-18-3

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

09

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 630-22-8

End Use API : Dabrafenib Mesylate

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank

10

BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed
arrow

CAS Number : 13036-57-2

End Use API : Dabrafenib Mesylate

About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

blank